Our Purpose: Better help Through Adherence
TED Talk: Why understanding patients is important to adherence
Achieving medication adherence must go beyond the use of a smart device. In this 5-minute TED Talk, AdhereTech Co-Founder Josh Stein discusses the top 3 principles that guided the AdhereTech approach to patient-centric design.
Get to know the team
Chief Executive Officer
Overall Career Driver:
Championing disruptive change to broadly impact patient health outcomes through collaborative and purpose-driven leadership.
Jeremy Gilbert
Chief Product Development Officer
Jeremy Gilbert
Overall Career Driver:
Leading teams that create and bring to market cutting-edge medical technologies that will help people live longer, healthier lives.
Whitney Salamone
Vice President of Commercial Operations
Whitney Salamone
Overall Career Driver:
Leveraging innovative and digital health solutions to enact positive behavior change in at-risk populations.
Ramy Elsisi
Chief Financial Officer
Ramy Elsisi
Overall Career Driver:
Transforming financial and operational results to maximize enterprise and shareholder value.
Gerald A Maguire, MD
Chief Medical Officer
Innes Meldrum
Chief Executive Officer
Innes Meldrum
Overall Career Driver:
Championing disruptive change to broadly impact patient health outcomes through collaborative and purpose-driven leadership.
Jeremy Gilbert
Chief Product Development Officer
Jeremy Gilbert
Overall Career Driver:
Leading teams that create and bring to market cutting-edge medical technologies that will help people live longer, healthier lives.
Whitney Salamone
Vice President of Commercial Operations
Whitney Salamone
Overall Career Driver:
Leveraging innovative and digital health solutions to enact positive behavior change in at-risk populations.
Ramy Elsisi
Chief Financial Officer
Ramy Elsisi
Overall Career Driver:
Transforming financial and operational results to maximize enterprise and shareholder value.
Gerald A Maguire, MD
Chief Medical Officer
AdhereTech Board Members
Neale Trangucci
Chair of the Board
Neale Trangucci retired in 2014 after 33 years on Wall Street in a variety of roles focused on investing in financially distressed companies. Mr. Trangucci is currently a member of the boards of directors of AdhereTech and Currax Pharmaceuticals. He earned a master’s degree in International Affairs from Columbia University and a Bachelor of Science degree from Bucknell University.
Dean McAlister
Independent Director and Executive Vice President, Inizio Biotech
Mr. McAlister has over 30 years of experience in the life sciences industry, including significant Senior Management operational experience within large Pharma and within services and solutions providers for the Pharma industry. He currently serves as Executive Vice President Inizio Biotech. His previous positions include EVP Global Biotech Enterprise Solutions for Ashfield Huntsworth, President of STEM North America and Executive Business Director, Astra Zeneca.
Dan Raynor
Argentum Private Equity
Dan Raynor is Managing Partner and co-founder of The Argentum Group, a New York-based growth equity firm that helps scale bootstrapped B2B software, technology-enabled, and business services companies. Mr. Raynor received a B.S. in economics from The Wharton School, University of Pennsylvania.
Paul Sekhri
Independent Director and CEO of vTv Therapeutics
Mr. Sekhri has over 35 years of experience in the Life Science Industry. His experience encompasses senior management in large corporate pharmaceutical and biotechnology companies, as well as private equity and venture capital. Mr. Sekhri has been a Director on more than 35 private, public company, and non-
profit Boards and is currently a member of the Board of Directors of eGenesis, Inc., Spring Discovery, and Veeva Systems Inc.
Elliot Zeelander
Mathers Private Equity
Elliot Zeelander has more than 30 years of investment management experience. Mr. Zeelander has been the sole General Partner and Managing Director of Mathers Associates since 2014. Today, Mathers manages $100 million, invests in public equity, primary and tertiary private equity, and has over 20 direct co-investments representing 50% of its assets. Mr. Zeelander sits on the boards of AdhereTech, Conner Industries, and EdgeIQ.
Josh Stein
AdhereTech Co-Founder
Josh Stein cofounded AdhereTech in 2011, providing the vision and business acumen to turn an idea into a thriving healthcare technology business that improves patients’ lives, and spans the complex markets of healthcare, software, enterprise sales,
hardware IoT, data analysis and clinical research. Mr. Stein earned his MBA from the Wharton School of Business and a BA from Washington University in St. Louis.
AdhereTech Board Advisors
Mark Awadalla
Vice President, CRDO, Capricor Therapeutic Inc.
Mr. Awadalla joined Capricor in 2023 serving as Vice President of Clinical Research & Development Operations overseeing all aspects of clinical development and trial execution. Mr. Awadalla specializes in cellular therapy clinical trials across multiple therapeutic areas such as oncology, inflammation, degenerative and rare diseases. He also has experience in clinical quality assurance, medical affairs and business development.